Results for
"[search-keyword]"
Sponsor content
811 result(s) found, displaying 411 to 420
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FINGOLIS fingolimod (as hydrochloride) 0.5 mg capsules blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LETROZOLE GH letrozole 2.5mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: emtricitabine; tenofovir disoproxil fumarate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-LETROZOLE letrozole 2.5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA IMATINIB Imatinib (as mesilate) 50 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLEVAC Imatinib (as mesilate) 50 mg capsule blister pack.